RYBELSUS

This brand name is authorized in Brazil, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom, United States

Active ingredients

The drug RYBELSUS contains one active pharmaceutical ingredient (API):

1	Semaglutide UNII 53AXN4NNHX - SEMAGLUTIDE
	Semaglutide is a GLP-1 receptor agonist. It acts in the same way as GLP-1 (a hormone produced in the gut) by increasing the amount of insulin that the pancreas releases in response to food. This helps with the control of blood glucose levels.
	Read more about Semaglutide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
RYBELSUS Tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BJ06		A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BJ Glucagon-like peptide-1 (GLP-1) analogues
Discover more medicines within A10BJ06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	526620120008707, 526620120008807, 526620120008907, 526620120009007, 526620120009107, 526620120009207, 526620120009307, 526620120009407, 526620120009507, 526620120009607, 526620120009707, 526620120009807
CA	Health Products and Food Branch	02497581, 02497603, 02497611
EE	Ravimiamet	1815814, 1815825, 1815836, 1815847, 1815869, 1815870, 1815881, 1815892, 1815904, 1815915
ES	Centro de información online de medicamentos de la AEMPS	1201430002, 1201430005, 1201430008
FI	Lääkealan turvallisuus- ja kehittämiskeskus	047094, 146870, 383205, 439552, 478961
FR	Base de données publique des médicaments	64596449, 66639842, 67593141
GB	Medicines & Healthcare Products Regulatory Agency	387319, 387322, 387325
IL	מִשְׂרַד הַבְּרִיאוּת	8786, 8787, 8788
IT	Agenzia del Farmaco	048719013, 048719025, 048719037, 048719049, 048719052, 048719064, 048719076, 048719088, 048719090, 048719102, 048719114, 048719126, 048719138, 048719140, 048719153
JP	医薬品医療機器総合機構	2499014F1021, 2499014F2028, 2499014F3024
LT	Valstybinė vaistų kontrolės tarnyba	1089852, 1089853, 1089854, 1089855, 1089856, 1089857, 1089858, 1089859, 1089860, 1089861, 1091558, 1091559, 1091560
NL	Z-Index G-Standaard, PRK	203394, 203408, 203416
PL	Rejestru Produktów Leczniczych	100434043, 100434050, 100434066
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66741001, W66741002, W66741003, W66741004, W66742002, W66742003, W66742004, W66743001, W66743002, W66743003
TR	İlaç ve Tıbbi Cihaz Kurumu	8699676011230, 8699676011247, 8699676011254, 8699676011261, 8699676011278, 8699676011285, 8699676011292, 8699676011308, 8699676011315
US	FDA, National Drug Code	0169-4303, 0169-4307, 0169-4314